BDR Pharma launches Nintenib (Nintedanib) to treat idiopathic pulmonary fibrosis in India
Nintenib is priced at Rs 750 (100 mg) and INR 900 (150 mg) for a pack of 10 tabs
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dharmesh Shah
BDR Pharma launches 80mg of Enzalutamide for prostate cancer treatment
BDR Pharmaceutical has launched 80mg advanced version of its Enzalutamide drug. Earlier the company had received the approval from…
Pharma firms initiate steps to curb black marketing of remedisivir
Measures include constant monitoring of the drug’s usage and ensuring its uninterrupted supply by working in collaboration with…
Experts ask govt to ensure access to remdesivir, raise concerns about supply shortage
Many also allude to an emerging black market for remdesivir in the country through which the drug is being sold at exorbitant…
Cipla, Hetero get DCGI nod to manufacture remdesivir
With this move, domestic production of remdesivir for “restricted emergency use” can begin
BDR Pharma urges regulators to expedite manufacturing, marketing license process for remdesivir
The company informed that central and state regulatory authorities have carried out an inspection of its API manufacturing site in…